7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| pmid:28302565 | ||||
| pmid:28189120 | ||||
| pmid:25184787 | ||||
| pmid:25181418 | ||||
| pmid:27256330 | ||||
| pmid:27255234 | ||||
| pmid:26447026 | ||||
| pmid:24975835 | ||||
| pmid:24948035 | ||||
| pmid:26923849 | ||||
| pmid:26909563 | ||||
| pmid:24697526 | ||||
| pmid:24689950 | ||||
| pmid:26584851 | ||||
| pmid:26581047 | ||||
| pmid:24249810 | ||||
| pmid:24212399 | ||||
| pmid:26362186 | ||||
| pmid:26361088 | ||||
| pmid:26112994 | ||||
| pmid:26099662 | ||||
| pmid:25868799 | ||||
| pmid:25866993 | ||||
| pmid:25865548 | ||||
| pmid:28260080 | ||||
| pmid:28259984 | ||||
| pmid:25643339 | ||||
| pmid:25634035 | ||||
| pmid:27849387 | ||||
| pmid:27845067 | ||||
| pmid:25446166 | ||||
| pmid:25442456 | ||||
| pmid:27664484 | ||||
| pmid:27663616 | ||||
| Wang Y et al. | Puerarin concurrently stimulates osteoprotegerin and inhibits receptor activator of NF-κB ligand (RANKL) and interleukin-6 production in human osteoblastic MG-63 cells. | Phytomedicine | pmid:24854571 | |
| pmid:12354528 | ||||
| pmid: | ||||
| Yamamoto N et al. | Resveratrol reduces prostaglandin E1-stimulated osteoprotegerin synthesis in osteoblasts: suppression of stress-activated protein kinase/c-Jun N-terminal kinase. | Prostaglandins Other Lipid Mediat. | pmid:25677506 | |
| Hofbauer LC and Heufelder AE | Osteoprotegerin: a novel local player in bone metabolism. | 1997 | Eur. J. Endocrinol. | pmid:9368500 |
| Simonet WS et al. | Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. | 1997 | Cell | pmid:9108485 |
| Kwon BS et al. | TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption. | 1998 | FASEB J. | pmid:9657524 |
| Yasuda H et al. | Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. | 1998 | Endocrinology | pmid:9492069 |
| Hofbauer LC et al. | Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9784422 |
| Matsuzaki K et al. | Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9600092 |
| Miyamoto A et al. | Establishment and characterization of an immortal macrophage-like cell line inducible to differentiate to osteoclasts. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9464281 |
| Takai H et al. | Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells. | 1998 | J. Biol. Chem. | pmid:9765225 |
| Lacey DL et al. | Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. | 1998 | Cell | pmid:9568710 |
| Tomoyasu A et al. | Characterization of monomeric and homodimeric forms of osteoclastogenesis inhibitory factor. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9571159 |
| Bucay N et al. | osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. | 1998 | Genes Dev. | pmid:9573043 |
| Yamaguchi K et al. | Characterization of structural domains of human osteoclastogenesis inhibitory factor. | 1998 | J. Biol. Chem. | pmid:9478964 |
| Yasuda H et al. | Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. | 1998 | Proc. Natl. Acad. Sci. U.S.A. | pmid:9520411 |
| Schinke T et al. | Molecular determinants of arterial calcification. | 1998 | Ann. Med. | pmid:9920355 |
| Akatsu T et al. | Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9753612 |
| Hakeda Y et al. | Osteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9790989 |
| Horwood NJ et al. | Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. | 1998 | Endocrinology | pmid:9794488 |
| Vidal NO et al. | Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells: down-regulation by glucocorticoids. | 1998 | J. Endocrinol. | pmid:9795357 |
| Filvaroff E and Derynck R | Bone remodelling: a signalling system for osteoclast regulation. | 1998 | Curr. Biol. | pmid:9768352 |
| Akatsu T et al. | Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy. | 1998 | Bone | pmid:9855457 |
| Morinaga T et al. | Cloning and characterization of the gene encoding human osteoprotegerin/osteoclastogenesis-inhibitory factor. | 1998 | Eur. J. Biochem. | pmid:9688283 |
| Emery JG et al. | Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. | 1998 | J. Biol. Chem. | pmid:9603945 |
| Tsukii K et al. | Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9610359 |
| Mizuno A et al. | Structure of the mouse osteoclastogenesis inhibitory factor (OCIF) gene and its expression in embryogenesis. | 1998 | Gene | pmid:9714833 |
| Mizuno A et al. | Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9647741 |
| Tsuda E and Higashio K | [Osteoclastogenesis inhibitory factor (OCIF)/OPG]. | 1998 | Nippon Rinsho | pmid:9648461 |
| Yamamoto M et al. | Hypocalcemic effect of osteoclastogenesis inhibitory factor/osteoprotegerin in the thyroparathyroidectomized rat. | 1998 | Endocrinology | pmid:9724059 |
| Hofbauer LC and Heufelder AE | Osteoprotegerin and its cognate ligand: a new paradigm of osteoclastogenesis. | 1998 | Eur. J. Endocrinol. | pmid:9724069 |
| Brändström H et al. | Tumor necrosis factor-alpha and -beta upregulate the levels of osteoprotegerin mRNA in human osteosarcoma MG-63 cells. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9703945 |
| Vidal ON et al. | Osteoprotegerin mRNA is increased by interleukin-1 alpha in the human osteosarcoma cell line MG-63 and in human osteoblast-like cells. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9703989 |
| Brändström H et al. | Regulation of osteoprotegerin mRNA levels by prostaglandin E2 in human bone marrow stroma cells. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9642127 |
| Yun TJ et al. | OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40. | 1998 | J. Immunol. | pmid:9834095 |
| Murakami T et al. | Transforming growth factor-beta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9837778 |
| Kong YY et al. | Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. | 1999 | Nature | pmid:10580503 |
| Spelsberg TC et al. | The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. | 1999 | Mol. Endocrinol. | pmid:10379881 |
| Burgess TL et al. | The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. | 1999 | J. Cell Biol. | pmid:10225954 |
| Nagai M and Sato N | Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation. | 1999 | Biochem. Biophys. Res. Commun. | pmid:10208850 |
| Hsu H et al. | Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. | 1999 | Proc. Natl. Acad. Sci. U.S.A. | pmid:10097072 |
| Shalhoub V et al. | Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors. | 1999 | J. Cell. Biochem. | pmid:10022507 |
| Hofbauer LC et al. | Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. | 1999 | Endocrinology | pmid:10499489 |
| Thomas RJ et al. | Breast cancer cells interact with osteoblasts to support osteoclast formation. | 1999 | Endocrinology | pmid:10499498 |
| Hofbauer LC | Osteoprotegerin ligand and osteoprotegerin: novel implications for osteoclast biology and bone metabolism. | 1999 | Eur. J. Endocrinol. | pmid:10474114 |
| Wickelgren I | Mining the genome for drugs. | 1999 | Science | pmid:10475849 |
| Hofbauer LC et al. | Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. | 1999 | Endocrinology | pmid:10465311 |
| Morony S et al. | A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNF-alpha, PTH, PTHrP, and 1, 25(OH)2D3. | 1999 | J. Bone Miner. Res. | pmid:10469275 |
| Sakata M et al. | Expression of osteoprotegerin (osteoclastogenesis inhibitory factor) in cultures of human dental mesenchymal cells and epithelial cells. | 1999 | J. Bone Miner. Res. | pmid:10469276 |
| Lazner F et al. | Osteopetrosis and osteoporosis: two sides of the same coin. | 1999 | Hum. Mol. Genet. | pmid:10469835 |
| Itonaga I et al. | 1,25-Dihydroxyvitamin D(3) and prostaglandin E(2) act directly on circulating human osteoclast precursors. | 1999 | Biochem. Biophys. Res. Commun. | pmid:10529407 |
| Nakagawa N et al. | Basic fibroblast growth factor inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D(3) through suppressing the production of osteoclast differentiation factor. | 1999 | Biochem. Biophys. Res. Commun. | pmid:10548488 |
| Nakagawa N et al. | Basic fibroblast growth factor induces osteoclast formation by reciprocally regulating the production of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in mouse osteoblastic cells. | 1999 | Biochem. Biophys. Res. Commun. | pmid:10548507 |
| Lee SK and Lorenzo JA | Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation. | 1999 | Endocrinology | pmid:10433211 |
| Ito H et al. | Hedgehog signaling molecules in bone marrow cells at the initial stage of fracture repair. | 1999 | Biochem. Biophys. Res. Commun. | pmid:10462495 |
| Yasuda H et al. | A novel molecular mechanism modulating osteoclast differentiation and function. | 1999 | Bone | pmid:10423033 |
| Roodman GD | Cell biology of the osteoclast. | 1999 | Exp. Hematol. | pmid:10428500 |
| Zhang XD et al. | Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma. | 1999 | Cancer Res. | pmid:10364001 |
| Kong YY et al. | Osteoprotegerin ligand: a common link between osteoclastogenesis, lymph node formation and lymphocyte development. | 1999 | Immunol. Cell Biol. | pmid:10234557 |
| Yano K et al. | Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis. | 1999 | J. Bone Miner. Res. | pmid:10234572 |
| Kanematsu M et al. | [Effects of gravity on the gene expression of osteoclast differentiation factor and osteoclastogenesis inhibitory factor]. | 1999 | Biol. Sci. Space | pmid:12532992 |
| Hofbauer LC et al. | The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. | 2000 | J. Bone Miner. Res. | pmid:10646108 |
| Kanzawa M et al. | Involvement of osteoprotegerin/osteoclastogenesis inhibitory factor in the stimulation of osteoclast formation by parathyroid hormone in mouse bone cells. | 2000 | Eur. J. Endocrinol. | pmid:10822231 |
| Quinn JM et al. | Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. | 2000 | J. Bone Miner. Res. | pmid:10934644 |
| Min H et al. | Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis. | 2000 | J. Exp. Med. | pmid:10952716 |